Oncology Institute Inc (TOI) — Defensive Interval Ratio
Oncology Institute Inc (TOI) has a Defensive Interval Ratio of 273 days as of March 2026. Defensive assets of $59.45 Million (cash $-, short-term investments $-, receivables $59.45 Million) cover 273 days of daily cash needs of $217.40K/day. See TOI net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Oncology Institute Inc Defensive Interval Ratio (2019–2025)
This chart shows how Oncology Institute Inc's Defensive Interval Ratio has evolved across 7 annual periods from 2019 to 2025. As of March 2026, the ratio stands at 273 days, meaning defensive assets of $59.45 Million can fund 273 days of operations without new revenue. See TOI equity financing ratio to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Oncology Institute Inc (2019–2025)
The table below presents the year-by-year Defensive Interval Ratio for Oncology Institute Inc from 2019 to 2025, covering 7 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Oncology Institute Inc market cap and net worth.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 305 days | $59.32 Million | $194.42K/day | $- | $- | ▼ -35 days |
| 2024 | 340 days | $48.68 Million | $143.05K/day | $- | $0.00 | ▼ -628 days |
| 2023 | 968 days | $92.28 Million | $95.31K/day | $- | $49.37 Million | ▼ -263 days |
| 2022 | 1231 days | $100.23 Million | $81.42K/day | $- | $59.80 Million | ▲ +971 days |
| 2021 | 260 days | $21.24 Million | $81.64K/day | $- | $0.00 | ▲ +40 days |
| 2020 | 220 days | $17.26 Million | $78.38K/day | $- | $- | ▼ -176 days |
| 2019 | 396 days | $14.73 Million | $37.22K/day | $- | $- | — |